Tokyo, Sept 25, 2009 (JCN) - Asahi Kasei Kuraray Medical will construct a new plant in Oita, Japan, for the manufacture of therapeutic apheresis devices. Production equipment currently in use, located in several separate production sections within the existing plant, will be transferred to the new plant and incorporated into integrated production lines featuring the latest technology.
The plant will produce the 'Plasmaflo' separator for plasmapheresis, 'Excelflo' filter for continuous renal replacement therapy (CRRT), 'Cellsorba' leukocytapheresis column, and other therapeutic apheresis devices. The company plans to invest 1.9 billion yen, with construction of the building from September 2009 to March 2010, and the transfer of production equipment from April 2010 to March 2011.
Therapeutic apheresis is used to treat a wide range of intractable diseases such as rheumatoid arthritis, ulcerative colitis, and hepatic insufficiency. Blood is drawn from a patient and circulated through a medical device which removes pathogenic substances by separation or adsorption; the treated blood is then returned to the patient. In many cases where there is no safe and effective drug, or where drug side effects are contraindicative, therapeutic apheresis may be the only available treatment.
Asahi Kasei Kuraray Medical is the world's leading producer of devices and systems for therapeutic apheresis, including the Plasmaflo hollow-fiber separator for plasmapheresis and the Immusorba plasma component absorption column, utilizing its leading technologies of membrane separation and selective absorption. Its effort to advance the development of high-performance blood purification systems includes working in coordination with front-line health care personnel to improve usability and to help heighten therapeutic skills.
Asahi Kasei Kuraray Mediacal is 93% owned by Asahi Kasei Corporation, and 7% owned by Kuraray Medical Inc.
Copyright © 2010 JCN. All rights reserved. A division of Japan Corporate News Network KK.
 Company Profile |  Print |  Alerts
|
 |
|
Asahi Kasei Integrates Bioprocess Businesses in North America
(Dec 31, 2009)
|
|
|
Asahi Kasei Kuraray Medical Establishes Sales Subsidiary in Korea
(Nov 1, 2009)
|
|
|
Asahi Kasei Launches 'Reveal DX' Insertable Cardiac Monitor
(Oct 1, 2009)
|
|
|
Asahi Kasei Kuraray Medical Building Plant for Therapeutic Apheresis Devices
(Sept 25, 2009)
|
|
|
Asahi Kasei Opens New 'Integrated Research Complex'
(Sept 2, 2009)
|
|
|
Japanese Chemical Makers Striving to Depend Less on Oil
(Aug 23, 2008)
|
|
|
Asahi Kasei to Sell U.S. Firm's Insertable Cardiac Monitor
(July 15, 2008)
|
|
|
Asahi Kasei Unit to Recycle Industrial Waste Water in China
(Apr 15, 2008)
|
|
|
Asahi Kasei to Set Up Thai Plants
(Mar 21, 2008)
|
|
|
Asahi Kasei Chemicals to Build New Battery Separator Plant
(Feb 27, 2008)
|
|
|
Recent
Health/Medical
News
|
RSS
|
|
|
|
|
Asahi Kasei Integrates Bioprocess Businesses in North America (Dec 31, 2009)
|
|
|
Asahi Kasei Kuraray Medical Establishes Sales Subsidiary in Korea (Nov 1, 2009)
|
|
|
Asahi Kasei Launches 'Reveal DX' Insertable Cardiac Monitor (Oct 1, 2009)
|
|
|
New RIKEN Robot to Assist in Care Facilities (Sept 29, 2009)
|
|
|
Asahi Kasei Kuraray Medical Building Plant for Therapeutic Apheresis Devices (Sept 25, 2009)
|
|
|
Teijin Develops World's First Bioplastic Eyeglasses (Sept 4, 2009)
|
|
|
Astellas Establishes Fund Laboratory 'Genome Medical Science Laboratory' at the University of Tokyo (Sept 4, 2009)
|
|
|
Kuraray Mediacal Obtains Approval for Artificial Bone Graft (Sept 2, 2009)
|
|
|
Daiichi Sankyo, Ranbaxy Launch Psteoporosis Medication EVISTA in Romania (Sept 2, 2009)
|
|
|
Pfizer and Astellas to Co-promote Hypertension, Hypercholesterolemia Treatment (Aug 31, 2009)
|
More Health/Medical news...
|
|
